Empyrean Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-388,000	Closed	-$44.9M	–	74
2023 Q3	$44.9M	Sell	388,000 -184,000	-32%	-$21.3M	2.77%	12
2023 Q2	$58.8M	Sell	572,000 -100,000	-15%	-$10.3M	2.66%	12
2023 Q1	$73.3M	Buy	672,000 +377,000	+128%	+$41.1M	2.51%	11
2022 Q4	$33.6M	Buy	+295,000	New	+$33.6M	1.06%	27